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Abstract Treatment of aspirinated platelets with the electro-
neutral K+/H+ exchanger nigericin induces a decrease in 
intraplatelet pH as measured with the intracellular fluorescent 
indicator BCECF. Under these conditions, the proton perme-
ability of the plasma membrane is unaffected. The addition of 
thrombin induces a rapid partial recovery of pH¡, which is 
completely abolished by the Na+/H+ exchanger inhibitor NHA. 
The effect is also evident in the presence of the PKC inhibitors 
GF109203X or staurosporine and in the absence of both external 
(EGTA-chelated) and internal (BAPTA-chelated) Ca2+. This 
makes the thrombin-induced activation of the exchanger 
independent of the involvement of the hitherto described 
activators, namely PKC and the increase in |Ca2+]¡, as well of 
the recently reported activator arachidonic acid [Cavallim, L., 
Coassin, M., Borean, A., and Alexandre, A. (1996) Biochem. J. 
319, 567-574], whose production requires a high [Ca2+]¡. The 
thrombin-dependent recovery of pH¡ is prevented by the 
phospholipase C inhibitor ET 18 O-CH3 and is mimicked by 
the addition of the permeable diglyceride dioctanoyl glycerol 
(DiCe) exogenously supplied. The effect of thrombin and EMCg is 
unaffected by inhibition of diacylglycerol Upase and diacylglyc-
erol kinase. These experiments identify diglyceride as a novel 
activator of the Na+/H+ exchanger in platelets. 
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1. Introduction 
Thrombin-induced alterations of pH¡ in human platelets 
appear to comprise two phases, an initial transient acidifica-
tion, followed by a second phase of prolonged alkalinization 
[1-5]. In the presence of inhibitors of the Na + /H + exchanger, 
or in Na+-free media, the increase in pH¡ is replaced by a 
long-lasting acidification, whose origin is not totally clear. It 
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Abbreviations: ArA, arachidonic acid; BAFTA-AM, l,2-bis-(2-ami-
nophenoxy)ethane-iV,JV,iV,JV'-tetraacetic acid tetraacetoxymethyl es-
ter; BCECF-AM, 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein 
triacetoxymethyl ester; BSA, bovine serum albumin; [Ca2+]i, cytosolic 
free Ca2+ concentration; ET I8-OCH3, l-O-octadecyl-20-methyl-rac-
glycero-3-phosphorylcholine; DiCs, 1,2-dioctanoyl-ín-glycerol; GF 
109203X, bisindolylmaleimide; INDO 1AM, l-(2-amino-5-(6-carboxy-
indol-2-yl)phenoxy)-2-(2'-amino-5'-methylphenoxy)ethane-iV,iV,iV', 
iV-tetraacetic acid pentaacetoxymethyl ester; NHA 5-(N,N-hesa-
methylene)amiloride; PGI2, prostaglandin I2 or prostacyclin; PKC, 
protein kinase C; PMA, phorbol, 12-myristate, 13-acetate; PRP, 
platelet-rich plasma; R 599949 diacylglygerol kinase inhibitor II, 3-(2-
(4-(bis(4-fluorophenyl)methylene)-l-piperidinyl)ethyl)-2,3-dihydro-2-
thioxo-4(lH)-quinazolinone; RHC-80267, l,6-bis(cyclohexyl-
aminocarbonylamino)hexane; Tg, thapsigargin. 
has been ascribed to increased H+ production because of in-
creased metabolic demands [6,1], or to stimulation of the 
plasma membrane-associated Ca2+-ATPase, which has been 
shown (in erythrocytes) to exchange external H + for internal 
Ca2+ [7,8]. More recently, it was recognized that ArA, whose 
production is stimulated by thrombin, activates a H+ conduc-
tance pathway across the plasma membrane, which leads to 
cytosolic acidification in the presence of negative plasma 
membrane potentials [9]. 
The prevailing alkalinization observed after thrombin in 
uninhibited platelets, which reflects the activation of the 
Na+/H+ exchanger, completely masks the effect of the pH¡-
decreasing processes) [1-5,10]. The activation of the exchang-
er has been shown to be mediated by the stimulation of PKC 
[1-5,9,11-15], as well as by the increase in [Ca2+]¡ [9,10,16]. 
We recently reported that ArA operates as a novel independ-
ent activator of the antiporter [9]. 
The present study analyzes in greater detail the properties 
of the Na+/H+ exchanger during thrombin-dependent platelet 
activation. It is shown that yet another activator can be de-
tected, under conditions where all the others are not opera-
tive. The new activator is identified as diglyceride produced by 
the activity of phosphatidylinositol-specific phospholipase C. 
2. Materials and methods 
2.1. Materials 
Hirudin, apyrase, ionomycin, Tg, NHA, BSA fraction V essentially 
fatty acid free, GF 109203X, Quin 2-AM and staurosporine were 
purchased from Sigma (St. Louis, MO, USA); BCECF-AM, BAP-
TA-AM, INDO 1AM, ET I8-OCH3, R 599949 and RHC-80267 were 
from Calbiochem, PGI2 from Cascade Biochem Ltd., UK; 
[5,6,8,9,11,12,14,15-3H]arachidonic acid was from Amersham. All 
other reagents were of analytical grade. 
2.2. Platelet preparation 
Platelet-rich plasma (PRP) and washed platelets were prepared and 
treated with aspirin as previously reported [17] from fresh blood 
drawn from healthy volunteers and mixed with acid citrate-dextrose 
anticoagulant supplemented with hirudin (50 mU/ml) apyrase (80 
mU/ml) and PGI2 (0.2 μg/pill). 
2.3. Determination of cytosolic pH 
The intracellular pH was determined with the fluorescent pH indi-
cator BCECF exactly as described in [9]. The pH-sensitive fluorescent 
probe BCECF-AM (5 μΜ) was added to aspirinated PRP and loading 
was performed for 30 min at 25°C. The pellet was resuspended in 
Tyrode buffer (145 mM NaCl, 5 mM KC1, 1 mM MgCl2, 20 mM 
Na-HEPES, 10 mM glucose, pH 7.4) in the presence of 40 mU/ml 
apyrase and 5 mU/ml hirudin. EGTA (0.2 mM) was added at the 
beginning of incubation. The platelets were used at a concentration 
of 0.5-1 X 108/ml. Fluorescence was measured at 25°C in a thermo-
stated, magnetically stirred cuvette, in a Shimadzu RL-5000 spectro-
fluorimeter with excitation and emission wavelengths set at 503 and 
530 nm, respectively. 
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2.4. Chelation of internal Ca2+ 
Chelation of internal Ca2+ was achieved by addition to PRP of 50 
μΜ BAPTA-AM 20 min after BCECF-AM, and prolonging the in-
cubation for 20-30 min more. Alternatively, chelation of internal 
Ca2+ was performed with Quin 2-AM (see below). 
2.5. [Ca2+]i measurement 
[Ca2+]i measurement was performed in INDO lAM-loaded plate-
lets as reported in [18] with excitation and emission wavelengths set at 
340 and 400 nm, respectively. 
2.6. PLA2 activity 
PLA2 activity was measured as [
3H]arachidonic acid release. 
Washed aspirinated platelets resuspended in Tyrode medium (buffered 
at pH 6.4 with citric acid) at a concentration of 3 X 109/ml were loaded 
with 3 μθί of carrier-free [3H]arachidonic acid for 90 min at room 
temperature, in the presence of hirudin (50 mU/ml), apyrase (80 mU/ 
ml) and PGI2 (0.2 μg/ml). At 60 min, one aliquot was withdrawn and 
treated with 100 μΜ Quin-AM for 30 min. After 5-fold dilution in the 
same medium, containing 3 mg/ml of BSA, and centrifugation at 
700 Xg for 12 min, the pellet was washed again and the cells resus-
pended in Tyrode buffer at pH 7.4 supplemented with 0.2 mM EGTA, 
at a concentration of 5X 108/ml. Platelets were equilibrated for 5 min 
at 25°C before addition of 0.3 U/ml thrombin. At the indicated times, 
aliquots were withdrawn and the reaction stopped by dilution with the 
same volume of an ice-cold mixture of 75 mM Na-phosphate buffer 
(pH 7.4) containing 4 mM EDTA and 6% (v/v) glutardialdehyde. 
After centrifugation at lOOOOXg for 3 min, the released 
[3H]arachidonate was measured in the supernatants by liquid-scintil-
lation counting (United Technologies Insta-gel). Values of 
[3H]arachidonate release were expressed as % of total counts of the 
corresponding suspension solubilized with 1% Triton X-100 and sub-
tracted from the basal value before stimulation. 
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Fig. 1. Effect of Tg, PMA, Ar A and thrombin on nigericin-acidified 
cytosol, in control and BAPTA-loaded, GF 109203X-treated plate-
lets. BCECF-loaded platelets untreated (A,B, - BAPTA) or co-
loaded with BAPTA (C,D, +BAPTA) were resuspended in Na + 
Tyrode as described in Section 2. Nigericin (Nig) was 25 ng/ml and 
GF 109203X (GF) was 2 μΜ (B,D). Further additions: Tg (0.4 
μΜ), PMA (50 nM), ArA (8 μΜ), followed by BSA (0.3 mg/ml) in 
A,C; thrombin (Thr, 0.3 U/ml) and NHA (20 μΜ, dotted line) in 
B,D. 
< 
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Fig. 2. Chelation of cytosolic Ca2+ prevents thrombin-induced pro-
duction of ArA. [3H]ArA-labelled platelets, untreated ( · ) or co-
loaded with Quin 2 (), were stimulated with thrombin (added at 
time zero). The points are taken from duplicate determinations from 
two platelet preparations. See Section 2 for details. 
3. Results and discussion 
A useful system to study the mechanisms of activation of 
the N a + / H + exchanger is to induce a controlled decrease in 
cytosolic p H (0.2-0.3 p H units) by adding small amounts of 
the electroneutral K + / H + exchanger nigericin to platelets sus-
pended in standard N a + Tyrode. Under these conditions, the 
subsequent addition of agents that promote the activation of 
the exchanger is expected to induce the recovery of p H . The 
effect of established activators of the antiporter is reported in 
Fig. 1 A. As shown, the recovery may be promoted by increas-
ing [Ca2+]i with the inhibitor of the endomembrane Ca 2 + -
ATPase Tg (the effect of Tg is also dependent in par t on 
the production of A r A [9]). Alternatively, the recovery may 
be promoted by the activation of P K C , with the phorbol ester 
P M A . Finally, as recently shown [9], exogenous A r A is cap-
able of activating a H + conductance pathway across the plas-
ma membrane as well as the N a + / H + antiporter; the effect of 
A r A on the antiporter is best evident when excess A r A is 
removed by BSA [9]. The effects of Tg, P M A and A r A are 
sensitive to the inhibitor of the N a + / H + exchanger, the 
amiloride derivative N H A [9]. Fig. IB demonstrates that rapid 
recovery of p H previously decreased by nigericin is also pro-
moted by thrombin. The effect of thrombin is mediated by the 
N a + / H + exchanger, as it is sensitive to N H A . 
If a similar experiment is conducted in platelets co-loaded 
with the C a 2 + chelator BAPTA, to prevent the increase in 
[Ca2+]i, and in the presence of the P K C inhibitor bisindolyl-
maleimide G F 109203X [19] or of staurosporine (2 μΜ, not 
shown), Tg and P M A lose their ability to promote the recov-
ery of pHi and only A r A (plus BSA) is still somewhat active 
(Fig. 1C; see also [9]). Interestingly, the NHA-sensitive recov-
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Fig. 3. Inhibition by ET I8-OCH3 of thrombin-induced Ca2+ release 
from intracellular stores. INDO lAM-loaded platelets were treated 
with thrombin (0.2 U/ml) in the absence (full line) and presence 
(dotted line) of ET I8-OCH3 (ET, 8 μΜ). When indicated Tg was 
0.4 μΜ, ionomycin 100 nM, and free Ca2+ 0.8 mM. The traces are 
representative of duplicate experiments with at least 5 different prep-
arations with similar results. 
ery of pH¡ induced by thrombin is almost unaffected (Fig. 
ID). This finding excludes the increase of [Ca2+]¡ and the 
activation of PKC as mediators of the thrombin effect. 
Also, the production of ArA, which is readily detectable 
upon supplementing thrombin in the absence of a cytosolic 
Ca2+ chelator, becomes undetectable when the agonist-in-
duced increase in cytosolic Ca2+ is prevented by loading 
with the Ca2+ chelator Quin 2 (Fig. 2). This finding also ex-
cludes ArA as the mediator of the thrombin-induced activa-
tion of the exchanger and shows that thrombin operates by 
yet another mechanism. 
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Fig. 4. Thrombin-induced recovery of pH¡ is sensitive to ET 18-
OCH3. BCECF-loaded platelets were co-loaded with BAPTA. When 
indicated ET I8-OCH3 (broken line) was 8 μΜ. The traces are rep-
resentative of duplicate experiments with at least 3 different prepara-
tions with similar results. 
Fig. 5. Recovery of pH¡ is promoted by the permeant diglyceride 
DiC8. BCECF-loaded platelets were co-loaded with BAPTA. When 
indicated DiC8 was 20 μΜ. Other additions: ET I8-OCH3 (A, 
broken line) 8 μΜ; ΝΗΑ 20 μΜ (Β). The traces are representative 
of duplicate experiments with 3 different preparations. 
To gain further insight into the mode by which thrombin 
activates the Na + /H + exchanger under the conditions of Fig. 
1C, we tried to determine whether its effect depends on the 
operation of the phosphatidylinositol-specific phospholipase 
C. To this end, we used the phospholipase C inhibitor ET 
I8-OCH3 [20]. An experiment showing the efficacy of ET 
I8-OCH3 as an inhibitor of the thrombin-induced increment 
of [Ca2+]i is reported in Fig. 3. ET I8-OCH3 induces a tran-
sient small increase in [Ca2+]i and prevents, as expected, the 
release of Ca2+ from the stores upon addition of thrombin. 
Ca2+ is then regularly released by the combined addition of 
Tg and a small concentration of ionomycin [18,21,22]. 
As shown in Fig. 4, although ET I8-OCH3 per se affects 
pH¡ to some extent, mainly by promoting a slow recovery 
after acidification with nigericin, it clearly inhibits the sharp 
recovery of p H induced by thrombin. This is an indication 
that phospholipase C may be required for induction of the 
thrombin effect. 
This finding led us to hypothesize that diglyceride may be 
the mediator of the thrombin activation of the Na + /H + ex-
changer. As shown in Fig. 5, the membrane-permeable digly-
ceride DiCe does indeed activate a NHA-sensitive recovery of 
pHj in BAPTA-loaded, protein kinase C-inhibited platelets. 
As may be expected, the effect of DiCg is not prevented by 
ET I8-OCH3. 
The activation of the Na + /H + exchanger by thrombin, or 
by the diglyceride DiCs does not depend on the formation of 
phosphatidic acid or other diacylglycerol metabolites as it is 
unaffected by the diacylglycerol kinase inhibitor II R 599949 
(3 μΜ) and the inhibitor of the diacylglycerol lipase RHC 
80267 (20 μΜ) (not shown). 
The findings reported in this study demonstrate that diglyc-
eride functions as a previously unidentified activator of the 
Na + /H + exchanger in platelets. The action of diglyceride, 
either endogenously produced or supplied as the membrane-
permeable DiCs, is independent of the intervention of pre-
viously recognized activators, including the elevation of 
[Ca2+]i, the activation of PKC or the production of ArA. 
Like the mentioned activators, diglyceride appears to operate 
by increasing the activity of the exchanger when the intra-
platelet pH is moderately decreased. 
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